Vaxil Bio Ltd (VXLLF)
0.0051
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Vaxil Bio Shareholders Equity (Quarterly): 0.6716M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.6716M |
September 30, 2023 | 0.6327M |
June 30, 2023 | 0.6693M |
March 31, 2023 | 0.7474M |
December 31, 2022 | 0.837M |
September 30, 2022 | 0.952M |
June 30, 2022 | 1.113M |
March 31, 2022 | 1.262M |
December 31, 2021 | 1.333M |
September 30, 2021 | 1.524M |
June 30, 2021 | 1.755M |
March 31, 2021 | 1.885M |
December 31, 2020 | 0.6305M |
September 30, 2020 | 0.1494M |
June 30, 2020 | 0.3039M |
March 31, 2020 | 0.2609M |
December 31, 2019 | -0.4463M |
September 30, 2019 | -0.0891M |
June 30, 2019 | 0.0472M |
March 31, 2019 | 0.1685M |
December 31, 2018 | 0.3194M |
September 30, 2018 | 0.6091M |
June 30, 2018 | 0.6291M |
March 31, 2018 | 0.7194M |
December 31, 2017 | -0.3873M |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.2214M |
March 31, 2017 | 0.4912M |
December 31, 2016 | 0.4866M |
September 30, 2016 | 0.9127M |
June 30, 2016 | 1.152M |
March 31, 2016 | 1.263M |
November 30, 2015 | -0.0627M |
August 31, 2015 | -0.0271M |
May 31, 2015 | 0.0277M |
February 28, 2015 | 0.2625M |
November 30, 2014 | 0.1248M |
August 31, 2014 | 0.1394M |
May 31, 2014 | 0.1733M |
February 28, 2014 | 0.2378M |
November 30, 2013 | 0.3424M |
August 31, 2013 | 0.5214M |
May 31, 2013 | 0.07M |
February 28, 2013 | 0.1407M |
November 30, 2012 | 0.1377M |
August 31, 2012 | 0.2065M |
May 31, 2012 | 0.2563M |
February 29, 2012 | 0.2585M |
November 30, 2011 | 0.3108M |
August 31, 2011 | 0.4088M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.4463M
Minimum
Dec 2019
1.885M
Maximum
Mar 2021
0.7494M
Average
0.6716M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.7357M |
Total Liabilities (Quarterly) | 0.0641M |